|Day's Range||0.0800 - 0.0800|
Colgate (CL) is benefiting from innovation plans, savings program and expansion strategies. However, increased raw material costs, higher SG&A expenses and currency woes remain concerns.
Colgate-Palmolive President and CEO, Noel Wallace, will present on Friday, February 21 at 8:00 am ET at the Consumer Analyst Group of New York Conference.
There are several positive factors supporting a continuation of the bull market that began in March 2009: interest rates are low, GDP growth is consistent and solid, earnings are poised to grow, and valuations are not yet overly stretched, forecasts John Eade, chairman and CEO of Argus Research Group.
Colgate-Palmolive shares extended their earnings rally Monday after a pair of analysts upgraded the stock and raised their price targets.
It's been a good week for Colgate-Palmolive Company (NYSE:CL) shareholders, because the company has just released its...
Church & Dwight's (CHD) Q4 sales improve on benefits from category growth and market share gains. However, earnings decline year over year.
Personal Income was lighter than expected last month, while Consumer Spending was in-line. Caterpillar, Exxon and Colgate all post Q4 results.
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0.00% and 1.85%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Colgate-Palmolive Co. stock rose 1.7% in Friday premarket trading after the consumer goods company reported fourth-quarter sales that beat expectations. Net income totaled $643 million, or 75 cents per share, up from $606 million, or 70 cents per share, last year. Adjusted EPS of 73 cents was in line with the FactSet consensus. Sales of $4.02 billion were up from $3.81 billion last year and ahead of the $3.93 billion FactSet guidance. Colgate-Palmolive shares are up 7.4% for the last year while the S&P 500 index is up 21.4% for the period.
Colgate-Palmolive Company (NYSE:CL) today reported worldwide Net sales of $4,015 million in fourth quarter 2019, an increase of 5.5% versus fourth quarter 2018. Global unit volume increased 5.5%, pricing increased 1.5% and foreign exchange was negative 1.5%. The previously disclosed acquisition of the Laboratoires Filorga Cosmétiques ("Filorga") skin health business contributed 2.0% to Net sales and unit volume growth in the quarter. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments) increased 5.0%.
Investing.com - Colgate-Palmolive (NYSE:CL) reported on Friday fourth quarter earnings that matched analysts' forecasts and revenue that topped expectations.
Colgate-Palmolive (NYSE: CL ) announces its next round of earnings this Friday, January 31. Here is Benzinga's everything-that-matters guide for the Q4 earnings announcement. Earnings and Revenue Analysts ...
The Zacks Analyst Blog Highlights: Colgate-Palmolive, Kellogg, The Hain Celestial Group and Post Holdings
Clorox (CLX) has been witnessing operational headwinds in the Charcoal, and Bags and Wraps businesses, which have been hurting its Household segment, and in turn the top line for a while now.
Fourth-quarter 2019 results have so far not been as disappointing as expected initially. However, overall earnings are still expected to dip.
Colgate's (CL) fourth-quarter 2019 results are likely to reflect benefits from its accelerated investment in brands, higher pricing, robust volume growth and strong innovation.
The same global economic volatilities that hurt Procter & Gamble’s earnings this quarter will likewise have an impact on other companies in the household and personal care space, according to an analyst at RBC Capital Markets.
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.